Skip to content
CancerIndex

Publication

Per- and polyfluoroalkyl substances levels other than PFOS, PFOA, or PFHxS and liver cancer risk: a nested case-control analysis.

Cody Z Watling, Jessica L Petrick, Barry I Graubard, Hyokyoung G Hong, Xuehong Zhang, Matthew J Barnett, Mollie E Barnard, Yu Chen, A Heather Eliassen, J Michael Gaziano, Wen-Yi Huang, Jae H Kang, Jill Koshiol, I-Min Lee, Erikka Loftfield, Steven C Moore, Lorelei A Mucci, Marian L Neuhouser, Christina C Newton, Howard D Sesso, Martha Shrubsole, Rashmi Sinha, Lesley Tinker, Matthew Triplette, Caroline Y Um, Kala Visvanathan, Jean Wactawski-Wende, Eleanor L Watts, Walter C Willett, Fen Wu, Wei Zheng, Peter T Campbell, Jonathan N Hofmann, Mark P Purdue, Dinesh Barupal, Katherine A McGlynn

Journal of the National Cancer InstituteSep 17, 2026PMID 42752878doi:10.1093/jnci/djag325 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 26, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260926-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Epidemiologic studies of PFAS and liver cancer risk have produced conflicting results with no strong or clear associations for pre-diagnostic perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and perfluorohexanesulfonate (PFHxS). We now report analyses of nine additional PFAS in a nested…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.